Why the study?
Does a low target INR (2.0-2.5) reduce thromboembolic and bleeding complications in patients with mechanical mitral valve replacement on warfarin therapy?
Population
135 patients who underwent mechanical mitral valve replacement (MVR) on warfarin therapy
Comparison
Warfarin therapy with a mean international… vs Warfarin therapy with a mean INR <2.0 or >2.5
Design
Cohort
Follow-up
mean 39.6 months
Authors
Loading...
May support INR 2.0-2.5 target in mechanical mitral valve patients; hypothesis-generating, needs randomized confirmation.
Does a low target INR (2.0-2.5) reduce thromboembolic and bleeding complications in patients with mechanical mitral valve replacement on warfarin therapy?
A lower target INR of 2.0-2.5 may be safe and effective for minimizing both thromboembolic and bleeding complications in patients with mechanical mitral valve replacement.
Bal et al. (2014) studied this question.